On the public citation graph
Recent Advances in Doxorubicin Formulation to Enhance Pharmacokinetics and Tumor Targeting
Inferred edges come from two machine sources: sweeps of open repository
metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is
labelled with the one it came from. Neither is a complete citation index — absence here is not
evidence of absence.
3 of the 180 references listed on this page are in the Retraction Watch database as retracted (export 2026-11-18): 10.1002/elsc.202200016 (notice 2025-07-14), 10.1007/s13346-020-00895-1 (notice 2023-12-05), 10.3389/fonc.2020.01756 (notice 2021-06-07).
Dataset join, best-effort; this page does not check the publisher record.
Retraction Watch data via Crossref Labs, used with credit; OpenCitations Index (CC0) and Meta (CC BY 4.0);
dataset doi:10.7910/DVN/WT8VOA (CC BY 4.0).
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated
CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/bdd.628openalex-snapshotDose‐independent pharmacokinetics of ondansetron in rats: contribution of hepatic and intestinal first‐pass effects to low bioavailability
inferredcites →https://doi.org/10.1002/elsc.202200016openalex-snapshotRETRACTED: Preparation of a pH‐responsive chitosan‐montmorillonite‐nitrogen‐doped carbon quantum dots nanocarrier for attenuating doxorubicin limitations in cancer therapy
inferredcites →https://doi.org/10.1002/hep.24740openalex-snapshotDickkopf 4 positively regulated by the thyroid hormone receptor suppresses cell invasion in human hepatoma cells
inferredcites →https://doi.org/10.1002/jcb.23210openalex-snapshotHyperglycemia regulates MDR-1, drug accumulation and ROS levels causing increased toxicity of carboplatin and 5-fluorouracil in MCF-7 cells
inferredcites →https://doi.org/10.1007/s10198-006-0034-1openalex-snapshotComparative cost-minimisation of oral and intravenous chemotherapy for first-line treatment of non-small cell lung cancer in the UK NHS system
inferredcites →https://doi.org/10.1007/s10637-010-9399-1openalex-snapshotA phase 2 study of SP1049C, doxorubicin in P-glycoprotein-targeting pluronics, in patients with advanced adenocarcinoma of the esophagus and gastroesophageal junction
inferredcites →https://doi.org/10.1007/s12038-020-00065-yopenalex-snapshotSensitization of hepatocellular carcinoma cells towards doxorubicin and sorafenib is facilitated by glucose-dependent alterations in reactive oxygen species, P-glycoprotein and DKK4
inferredcites →https://doi.org/10.1007/s40005-022-00595-7openalex-snapshotA comparative evaluation of anti-tumor activity following oral and intravenous delivery of doxorubicin in a xenograft model of breast tumor
inferredcites →https://doi.org/10.1007/s40005-022-00606-7openalex-snapshotPharmacokinetic modulation of substrate drugs via the inhibition of drug-metabolizing enzymes and transporters using pharmaceutical excipients
inferredcites →https://doi.org/10.1016/j.bbrc.2016.03.002openalex-snapshotGlucose regulated protein 78 (GRP78) inhibits apoptosis and attentinutes chemosensitivity of gemcitabine in breast cancer cell via AKT/mitochondrial apoptotic pathway
inferredcites →https://doi.org/10.1016/j.ijpharm.2015.02.034openalex-snapshotLarge-scale manufacturing of GMP-compliant anti-EGFR targeted nanocarriers: Production of doxorubicin-loaded anti-EGFR-immunoliposomes for a first-in-man clinical trial
inferredcites →https://doi.org/10.1016/j.ijpharm.2022.121479openalex-snapshotOleanolic acid-conjugated human serum albumin nanoparticles encapsulating doxorubicin as synergistic combination chemotherapy in oropharyngeal carcinoma and melanoma
inferredcites →https://doi.org/10.1016/j.ijpx.2021.100089openalex-snapshotOral etoposide and zosuquidar bioavailability in rats: Effect of co-administration and in vitro-in vivo correlation of P-glycoprotein inhibition
inferredcites →https://doi.org/10.1016/j.jep.2016.12.051openalex-snapshotApoptosis induced by the methanol extract of Salvia miltiorrhiza Bunge in non-small cell lung cancer through PTEN-mediated inhibition of PI3K/Akt pathway
inferredcites →https://doi.org/10.1016/s1470-2045(12)70476-xopenalex-snapshotTolerability, safety, pharmacokinetics, and efficacy of doxorubicin-loaded anti-EGFR immunoliposomes in advanced solid tumours: a phase 1 dose-escalation study
inferredcites →https://doi.org/10.1021/ar200234qopenalex-snapshotpH-Responsive Nanoparticles Shelled with Chitosan for Oral Delivery of Insulin: From Mechanism to Therapeutic Applications
inferredcites →https://doi.org/10.1021/mp200011fopenalex-snapshotAugmented Anticancer Efficacy of Doxorubicin-Loaded Polymeric Nanoparticles after Oral Administration in a Breast Cancer Induced Animal Model
inferredcites →https://doi.org/10.1021/mp500833mopenalex-snapshotImproved Oral Absorption of Doxorubicin by Amphiphilic Copolymer of Lysine-Linked Ditocopherol Polyethylene Glycol 2000 Succinate: In Vitro Characterization and in Vivo Evaluation
inferredcites →https://doi.org/10.1038/ncomms2921openalex-snapshotDrug-induced histone eviction from open chromatin contributes to the chemotherapeutic effects of doxorubicin
inferredcites →https://doi.org/10.1038/sj.bjc.6601856openalex-snapshotPhase I dose escalation and pharmacokinetic study of pluronic polymer-bound doxorubicin (SP1049C) in patients with advanced cancer
inferredcites →https://doi.org/10.1038/sj.bjc.6603059openalex-snapshotPharmacoeconomic analysis of adjuvant oral capecitabine vs intravenous 5-FU/LV in Dukes' C colon cancer: the X-ACT trial
inferredcites →https://doi.org/10.1039/c9tb00212jopenalex-snapshotIntestine-penetrating, pH-sensitive and double-layered nanoparticles for oral delivery of doxorubicin with reduced toxicity
inferredcites →https://doi.org/10.1073/pnas.0807691105openalex-snapshotPten null prostate tumorigenesis and AKT activation are blocked by targeted knockout of ER chaperone GRP78/BiP in prostate epithelium
inferredcites →https://doi.org/10.1080/10428190701190169openalex-snapshotPhase I/II trial of a P-glycoprotein inhibitor, Zosuquidar.3HCl trihydrochloride (LY335979), given orally in combination with the CHOP regimen in patients with non-Hodgkin's lymphoma
inferredcites →https://doi.org/10.1080/10715762.2019.1628957openalex-snapshotAscorbate promotes the cellular accumulation of doxorubicin and reverses the multidrug resistance in breast cancer cells by inducing ROS-dependent ATP depletion
inferredcites →https://doi.org/10.1093/neuonc/nou265.21openalex-snapshotNT-23 * PHASE 1/2A STUDY OF GLUTATHIONE PEGYLATED LIPOSOMAL DOXORUBICIN (2B3-101) IN BREAST CANCER PATIENTS WITH BRAIN METASTASES (BCBM) OR RECURRENT HIGH GRADE GLIOMAS (HGG)
inferredcites →https://doi.org/10.1111/bcp.14886openalex-snapshotOral paclitaxel with encequidar compared to intravenous paclitaxel in patients with advanced cancer: A randomised crossover pharmacokinetic study
inferredcites →https://doi.org/10.1111/cas.14373openalex-snapshotElevation of CD109 promotes metastasis and drug resistance in lung cancer via activation of EGFR‐AKT‐mTOR signaling
inferredcites →https://doi.org/10.1166/jnn.2018.16409openalex-snapshotpH-Sensitive DOX-Loaded PAA-PF127-PAA Micelles Combined with Cryotherapy for Treating Walker 256 Carcinosarcoma in a Rat Model
inferredcites →https://doi.org/10.1172/jci45600openalex-snapshotMultimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma
inferredcites →https://doi.org/10.1186/s13046-018-0689-3openalex-snapshotSOX2OT variant 7 contributes to the synergistic interaction between EGCG and Doxorubicin to kill osteosarcoma via autophagy and stemness inhibition
inferredcites →https://doi.org/10.1200/jco.2002.12.116openalex-snapshotIncreased Oral Bioavailability of Topotecan in Combination With the Breast Cancer Resistance Protein and P-Glycoprotein Inhibitor GF120918
inferredcites →https://doi.org/10.1248/bpb.b14-00508openalex-snapshotEnhanced Oral Bioavailability of Morin Administered in Mixed Micelle Formulation with PluronicF127 and Tween80 in Rats
inferredcites →https://doi.org/10.2147/ott.s221228openalex-snapshotTanshinone IIA Reverses Gefitinib-Resistance In Human Non-Small-Cell Lung Cancer Via Regulation Of VEGFR/Akt Pathway
inferredcites →https://doi.org/10.3389/fonc.2020.01756openalex-snapshotRETRACTED: Combination of Tanshinone IIA and Cisplatin Inhibits Esophageal Cancer by Downregulating NF-κB/COX-2/VEGF Pathway
inferredcites →https://doi.org/10.3390/biom9030098openalex-snapshotThe Main Metabolites of Fluorouracil + Adriamycin + Cyclophosphamide (FAC) Are Not Major Contributors to FAC Toxicity in H9c2 Cardiac Differentiated Cells
inferredcites →https://doi.org/10.3390/pharmaceutics12030268openalex-snapshotComparative Pharmacokinetics and Pharmacodynamics of a Novel Sodium-Glucose Cotransporter 2 Inhibitor, DWP16001, with Dapagliflozin and Ipragliflozin
inferredcites →https://doi.org/10.3390/pharmaceutics12090882openalex-snapshotEnhanced Intestinal Absorption and Pharmacokinetic Modulation of Berberine and Its Metabolites through the Inhibition of P-Glycoprotein and Intestinal Metabolism in Rats Using a Berberine Mixed Micelle Formulation
inferredcites →https://doi.org/10.3390/pharmaceutics13122181openalex-snapshotPEGylated Liposomes Remotely Loaded with the Combination of Doxorubicin, Quinine, and Indocyanine Green Enable Successful Treatment of Multidrug-Resistant Tumors
inferredcites →https://doi.org/10.3762/bjnano.10.166openalex-snapshotDoxorubicin-loaded human serum albumin nanoparticles overcome transporter-mediated drug resistance in drug-adapted cancer cells
inferredcites →https://doi.org/10.3802/jgo.2021.32.e9openalex-snapshotRandomized phase III trial comparing pegylated liposomal doxorubicin (PLD) at 50 mg/m2 versus 40 mg/m2 in patients with platinum-refractory and -resistant ovarian carcinoma: the JGOG 3018 Trial
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4856703openalex-extractedTowards the Preparation of Smart Drug Delivery Platforms for Colorectal Cancer Therapy: Biocompatible and Targeted Mesoporous Silica Nanoparticles with Deferiprone-Copper Complex Gatekeeper
inferred← citeshttps://doi.org/10.1002/adtp.202500085openalex-snapshotOral Doxorubicin Lipid Nanoparticles Enhance Triple‐Negative Breast Cancer Therapy via Immune Activation and Reduced Cardiotoxicity
inferred← citeshttps://doi.org/10.1002/agt2.480openalex-snapshotA panoramic perspective of recent progress in 2D and 3D covalent organic frameworks for drug delivery
inferred← citeshttps://doi.org/10.1002/ddr.22196openalex-snapshotApigenin alleviates doxorubicin‐induced myocardial pyroptosis by inhibiting glycogen synthase kinase‐3β in vitro and in vivo
inferred← citeshttps://doi.org/10.1002/marc.70360openalex-snapshotPhotocontrolled Drug Release From Donor–Acceptor Stenhouse Adduct Amphiphile Doped Laden Polymeric Hydrogel
inferred← citeshttps://doi.org/10.1007/978-981-95-3698-6_2openalex-snapshotIn Silico Pharmacokinetic Analysis of Topical Administration of Liposomal Nano-Drug across Different Human Skin Types: A Compartmental Numerical Approach
inferred← citeshttps://doi.org/10.1007/s00289-023-05099-4openalex-snapshotExploring the potential use of natural polymers to enhance the performance of MXene/MOF-5 nanocarrier in loading and co-loading of doxorubicin and curcumin
inferred← citeshttps://doi.org/10.1007/s10904-024-03173-6openalex-snapshotPolydopamine-Coated Zn-MOF-74 Nanocarriers: Versatile Drug Delivery Systems with Enhanced Biocompatibility and Cancer Therapeutic Efficacy
inferred← citeshttps://doi.org/10.1007/s12257-024-00064-yopenalex-snapshotBioanalysis of ursodeoxycholic acid and its metabolites and improved oral bioavailability using mixed micelles with poloxamer 407 and polysorbate 80
inferred← citeshttps://doi.org/10.1007/s13346-024-01648-0openalex-snapshotA comprehensive review on doxorubicin: mechanisms, toxicity, clinical trials, combination therapies and nanoformulations in breast cancer
inferred← citeshttps://doi.org/10.1016/j.ijbiomac.2024.135894openalex-snapshotA thermo-responsive chemically crosslinked long-term-release chitosan hydrogel system increases the efficiency of synergy chemo-immunotherapy in treating brain tumors
inferred← citeshttps://doi.org/10.1016/j.ijbiomac.2026.154244openalex-snapshotCo-delivery of doxorubicin and silybin via taurine-conjugated chitosan-modified TAUT-targeted liposomes enhances oral bioavailability and alleviates doxorubicin-induced cardiomyocyte toxicity in vitro
inferred← citeshttps://doi.org/10.1016/j.ijpharm.2026.127540openalex-snapshotErythrocyte-membrane camouflaged manganese dioxide-polydopamine nanocarriers for doxorubicin delivery and MRI-visualized chemo-photothermal cancer therapy
inferred← citeshttps://doi.org/10.1016/j.jddst.2024.106087openalex-snapshotTowards the preparation of smart drug delivery platforms for colorectal cancer therapy: Biocompatible and targeted mesoporous silica nanoparticles with the deferiprone-copper complex gatekeeper
inferred← citeshttps://doi.org/10.1016/j.jddst.2025.106980openalex-snapshotMarine L-arginase encapsulated in poly (lactic-co-glycolic acid) nanoparticles: A novel anti-cancer strategy for effective hepatocellular carcinoma treatment in vitro and in vivo
inferred← citeshttps://doi.org/10.1016/j.jpba.2025.117012openalex-snapshotMapping the polar metabolome in Huh-7 liver cancer cells reveal the role of atorvastatin in enhancing chemotherapeutic efficacy of doxorubicin
inferred← citeshttps://doi.org/10.1016/j.jtice.2025.105992openalex-snapshotHydrolysis-assisted synthesis of magnetic iron oxide-silica/poly(methacrylic acid) nanocomposites for pH- and thermo-responsive doxorubicin delivery
inferred← citeshttps://doi.org/10.1016/j.metop.2025.100440openalex-snapshotProtective effects of medicinal honey against doxorubicin-induced hepatorenal toxicity in rats: A novel grading index (PAD score) based on phenolic content and antioxidant capacity
inferred← citeshttps://doi.org/10.1021/acsabm.4c00552openalex-snapshotInterrogating the Role of Endocytosis Pathway and Organelle Trafficking for Doxorubicin-Based Combination Ionic Nanomedicines
inferred← citeshttps://doi.org/10.1039/d6md00084copenalex-snapshotBeyond infection control: exploring the therapeutic potential of antimicrobials in oncology and their synthetic perspectives
inferred← citeshttps://doi.org/10.1063/5.0275809openalex-snapshotThree-dimensional finite element modelling of chemical environment in droplet-based microfluidic systems for drug therapy applications
inferred← citeshttps://doi.org/10.1101/2025.01.04.631287openalex-snapshotTargeting and combating drug resistance in triple-negative breast cancer using nano polymer: Efficacy of A6 peptide-PLGA-PEG nanoparticle loaded with doxorubicin and anti-miR-21 in in vitro and vivo model
inferred← citeshttps://doi.org/10.1111/bph.70085openalex-snapshotDexrazoxane protects against doxorubicin‐induced cardiotoxicity in susceptible human living myocardial slices: A proof‐of‐concept study
inferred← citeshttps://doi.org/10.2147/bctt.s501448openalex-snapshotFrom Pioneering Discoveries to Innovative Therapies: A Journey Through the History and Advancements of Nanoparticles in Breast Cancer Treatment
inferred← citeshttps://doi.org/10.3389/fmolb.2024.1494257openalex-snapshotProtein-free domains in native and ferroptosis-driven oxidized cell membranes: a molecular dynamics study of biophysical properties and doxorubicin uptake
inferred← citeshttps://doi.org/10.3390/biom16010137openalex-snapshotMagnetic Nanocarriers with ICPTES- and GPTMS-Functionalized Quaternary Chitosan for pH-Responsive Doxorubicin Release
inferred← citeshttps://doi.org/10.3390/ijms26093966openalex-snapshotUnderstanding the Mechanisms of Chemotherapy-Related Cardiotoxicity Employing hiPSC-Derived Cardiomyocyte Models for Drug Screening and the Identification of Genetic and Epigenetic Variants
inferred← citeshttps://doi.org/10.3390/molecules30030676openalex-snapshotComprehensive Methodology for Evaluating the Drug Loading of Iron Oxide Nanoparticles Using Combined Magnetometry and Mössbauer Spectroscopy
inferred← citeshttps://doi.org/10.3390/molecules31030557openalex-snapshotGinsenoside Rg5 Targets PRDX1 to Disrupt Redox Homeostasis and Induce Mitochondria-Dependent Apoptosis in Human Hepatocellular Carcinoma HepG2 Cells
inferred← citeshttps://doi.org/10.3390/ph18091244openalex-snapshotPhytocannabinoids and Nanotechnology in Lung Cancer: A Review of Therapeutic Strategies with a Focus on Halloysite Nanotubes
inferred← citeshttps://doi.org/10.3390/pharmaceutics16060739openalex-snapshotHybrid Nanosystem Formed by DOX-Loaded Liposomes and Extracellular Vesicles from MDA-MB-231 Is Effective against Breast Cancer Cells with Different Molecular Profiles
inferred← citeshttps://doi.org/10.3390/pharmaceutics17020202openalex-snapshotPreparing a Liposome-Aided Drug Delivery System: The Entrapment and Release Profiles of Doxorubicin and 9-(N-Piperazinyl)-5-methyl-12(H)-quino [3,4-b][1,4]benzothiazinium Chloride with Human Serum Albumin
inferred← citeshttps://doi.org/10.34172/bi.30848openalex-snapshotEnhanced efficacy of breast cancer treatment with etoposide-graphene oxide nanogels: A novel nanomedicine approach
inferred← citeshttps://doi.org/10.34172/jhp.2026.53139openalex-snapshotCytotoxicity activity and in silico studies from ethanol, ethyl acetate, and n-hexane extracts of Marchantia paleacea liverwort herb on MCF-7 and T47D breast cancer cells
inferred← citeshttps://doi.org/10.51435/turkjac.1433347openalex-snapshotValidation of High-Performance Liquid Chromatography method for the determination of doxorubicin in proliposomal drug delivery system formulation
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID:
icsacinstitute.org/submit.